Staphylococcus aureus News and Research

RSS

Staphylococcus aureus is a spherical bacterium (coccus) which on microscopic examination appears in pairs, short chains, or bunched, grape-like clusters. These organisms are Gram-positive. Some strains are capable of producing a highly heat-stable protein toxin that causes illness in humans.

Artificial intelligence enables discovery of novel compounds to fight drug-resistant bacteria

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).

14 Aug 2025

Study: Lignin shows strong antiviral and antibacterial properties

Research from the Nanoscience Center of the University of Jyväskylä, Finland, has revealed that lignin, a polyphenol, important for plant structure, has antimicrobial activity against viruses and bacteria.

12 Aug 2025

Novel hydrogel accelerates infected wound repair with antibacterial properties

A novel ε-poly-L-lysine-loaded sodium-alginate/gelatin hydrogel (PSG15) has shown exceptional promise in accelerating the healing of infected wounds. This multifunctional injectable hydrogel delivers robust antibacterial properties while regulating macrophage polarization and stabilizing the skin microbiota.

8 Aug 2025

Innovative implant material combines bone regeneration and infection control

A research team from Shanghai Jiao Tong University has resulted in a significant advancement in the field of orthopedic implant materials.

6 Aug 2025

Understanding immune drift in biologic therapy for inflammatory skin diseases

Immune-inflammatory skin diseases (e.g., psoriasis, atopic dermatitis) involve dysregulation of CD4+ T-cell subsets (Th1/Th2/Th17/Treg) and cytokine networks (IL-17/IL-23/IL-4).

28 Jul 2025

AI turns old diabetes drug Halicin into a potent weapon against superbugs

Researchers found that Halicin, an AI-identified drug, effectively inhibited most multidrug-resistant bacteria except Pseudomonas aeruginosa. The study highlights Halicin’s broad-spectrum antibacterial potential and the transformative role of artificial intelligence in antibiotic discovery.

20 Jul 2025

New study maps bacterial communication to fight MRSA infections

Imagine two people talking over a walkie-talkie set. Successful communication depends on them being tuned to the same frequency.

16 Jul 2025

Staph bacterium possesses a surprising level of metabolic redundancy, study reveals

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we target deadly pathogens like staph infections.

16 Jul 2025

Therapeutic potential of houttuynia cordata polysaccharide in H1N1 and MRSA-induced acute pneumonia

This new article publication from Acta Pharmaceutica Sinica B, discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.

12 Jul 2025

New nanoparticle platform breaks through MRSA biofilms

A major cause of hospital-acquired infections, the super bacteria Methicillin-resistant Staphylococcus aureus (MRSA), not only exhibits strong resistance to existing antibiotics but also forms a dense biofilm that blocks the effects of external treatments.

14 Jun 2025

Green light activates modified penicillin to target bacterial infections

To treat bacterial infections, medical professionals prescribe antibiotics. But not all active medicine gets used up by the body.

12 Jun 2025

Nanoplastics reshape gut microbiome, weakening gut defenses

Polystyrene nanoplastics impact gut health by modifying microbiota interactions via extracellular vesicles, raising concerns about environmental nanoplastics.

12 Jun 2025

Antibiotic use predicts microbiota dysbiosis in preterm infants

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting long-term health outcomes.

11 Jun 2025

When old diseases find new ways in: Europe’s latest diphtheria outbreak explained

A large multicountry outbreak of toxigenic Corynebacterium diphtheriae occurred among migrants entering Europe in 2022, driven primarily by cutaneous infections and involving multiple genetic lineages. Despite the unprecedented surge, transmission to resident populations was limited, but rising antimicrobial resistance and delayed treatment highlight ongoing public health risks.

10 Jun 2025

New compound infuzide shows promise against resistant bacterial infections

Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, according to the World Health Organization. Staphylococcus aureus and Enterococcus sp., 2 gram-positive pathogens highly likely to develop resistance to known treatments, can cause dangerous hospital-acquired and community-acquired infections.

2 Jun 2025

Light-powered phagocytic macrophage microrobot combines immune functions with robotic controllability

Macrophages and other immune cells are the natural frontline immune warriors of our body, defending the body against invading pathogens and cancer cells.

31 May 2025

New glycopeptide antibiotic discovered to combat resistant bacteria

An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide antibiotic.

14 May 2025

Experimental cancer drug shows promise in boosting tuberculosis treatment

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, based on mouse-model research of the lung-damaging disease.

21 Apr 2025